Human iPSC–Derived Endothelial Cells Exhibit Reduced Immunogenicity in Comparison With Human Primary Endothelial Cells
Human induced pluripotent stem cell (iPSC)–derived endothelial cells (ECs) have emerged as a promising source of autologous cells with great potential to produce novel cell therapy for ischemic vascular diseases. However, their clinical application still faces numerous challenges including safety co...
        Saved in:
      
    
          | Main Authors: | Haiyan Jia, Melanie Moore, Meenu Wadhwa, Chris Burns | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Wiley
    
        2024-01-01 | 
| Series: | Stem Cells International | 
| Online Access: | http://dx.doi.org/10.1155/sci/6153235 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Human iPSC-derived myelinating organoids and globoid cells to study Krabbe disease.        
                          
 by: Lisa Marie P Evans, et al.
 Published: (2024-01-01)
- 
                
                    The role of phosphofructokinase P in hypertrophy of iPSC-derived human cardiomyocytes        
                          
 by: Katarzyna Kmiotek, et al.
 Published: (2024-11-01)
- 
                
                    Human iPSC-derived neural stem cells engraft and improve pathophysiology of MPS I mice        
                          
 by: Caitlin C. Calhoun, et al.
 Published: (2024-12-01)
- 
                
                    Transcriptome-wide RNA 5-methylcytosine profiles of human iPSCs and iPSC-derived cardiomyocytes        
                          
 by: Szu-Ying Chen, et al.
 Published: (2024-12-01)
- 
                
                    The Effects of Co-injecting Human iPSC-Derived Cardiomyocytes/Pre-epicardial Cells into Cryoinjured Rat Hearts        
                          
 by: Fatin Fazrina Roslan, et al.
 Published: (2024-07-01)
 
       